IQVIAs analysis of IRA commercial impact shows that the net present value of a small-molecule drugs commercial opportunity declines by an estimated 40 to 60 percent relative to the pre-IRA environment, depending on indication, Medicare share of revenues, and time to negotiation eligibility
Back Bell, GI, Sangez-Pescador, R, Laybourn, PJ, Najarian RC (1983) 'Exon duplication and divergence in the human preproglucagon gene', Nature , 304, 368-71
Naltrexone ( ReVia, Vivitrol) was designed for opioid use disorder and later became a cornerstone treatment for alcohol cravings and binge eating
Semaglutide is a GLP-1 receptor agonist, while Tirzepatide works as a dual GIP and GLP-1 receptor agonist, offering an enhanced metabolic response